News - Eliquis, Portola Pharmaceuticals

Filter

Popular Filters

Bristol-Myers and Pfizer collaborate on Eliquis study with Portola's universal Factor Xa inhibitor antidote PRT4445

05-11-2012

Portola Pharmaceuticals, Bristol-Myers Squibb (NYSE: BMY) and Pfizer (NYSE: PFE) last week announced…

Bristol-Myers SquibbCardio-vascularEliquisPfizerPharmaceuticalPortola PharmaceuticalsPRT4445Research

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top